$MGNX
MACROGENICS INC Stock $mgnx

$mgnx Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-Q Financial Statement

#000112534518000084 Filed on August 07, 2018

Income Statement

Concept	2018 Q3	2018 Q2	2017 Q2
Revenue	$20.80M	$18.83M	$1.666M
YoY Change	1150.63%	1030.49%	-97.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$9.600M	$11.10M	$8.400M
YoY Change	14.29%	32.14%	16.67%
% of Gross Profit
Research & Development	$46.22M	$52.01M	$34.46M
YoY Change	12.77%	50.94%	3.36%
% of Gross Profit
Depreciation & Amortization	$2.730M	$1.200M	$2.000M
YoY Change	42.93%	-40.0%	11.73%
% of Gross Profit
Operating Expenses	$46.22M	$52.01M	$34.46M
YoY Change	12.77%	50.94%	3.36%
Operating Profit	-$35.00M	-$44.31M	-$41.18M
YoY Change	-26.65%	7.61%	-202.71%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$975.0K	$1.070M	$525.0K
YoY Change	43.17%	103.81%	41.89%
Pretax Income	-$34.00M	-$43.20M	-$40.70M
YoY Change	-27.66%	6.14%	-200.49%
Income Tax
% Of Pretax Income
Net Earnings	-$34.03M	-$43.24M	-$40.65M
YoY Change	-27.66%	6.37%	-200.47%
Net Earnings / Revenue	-163.62%	-229.61%	-2440.22%
Basic Earnings Per Share			-$1.14
Diluted Earnings Per Share	-$805.7K	-$1.024M	-$1.14
COMMON SHARES
Basic Shares Outstanding	42.24M shares	42.15M shares	35.78M shares
Diluted Shares Outstanding		42.15M shares	35.78M shares

Balance Sheet

Concept	2018 Q3	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$260.1M	$300.9M	$243.7M
YoY Change	27.75%	23.47%	-8.25%
Cash & Equivalents	$201.8M	$238.7M	$116.6M
Short-Term Investments	$58.30M	$62.20M	$127.0M
Other Short-Term Assets	$4.500M	$3.400M	$4.500M
YoY Change	21.62%	-24.44%	0.0%
Inventory
Prepaid Expenses	$4.315M	$3.173M	$4.008M
Receivables	$20.97M	$17.84M	$1.991M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$285.6M	$322.1M	$250.1M
YoY Change	36.37%	28.76%	-28.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$58.65M	$57.49M	$23.18M
YoY Change	90.18%	148.03%	26.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$0.00
YoY Change
Other Assets	$11.07M	$7.346M	$1.553M
YoY Change	618.04%	373.02%	-26.05%
Total Long-Term Assets	$69.71M	$64.84M	$24.73M
YoY Change	115.31%	162.16%	20.64%
TOTAL ASSETS
Total Short-Term Assets	$285.6M	$322.1M	$250.1M
Total Long-Term Assets	$69.71M	$64.84M	$24.73M
Total Assets	$355.4M	$386.9M	$274.8M
YoY Change	46.94%	40.77%	-25.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$986.0K	$1.767M	$2.088M
YoY Change	-41.31%	-15.37%	74.0%
Accrued Expenses	$38.48M	$37.18M	$22.32M
YoY Change	50.88%	66.59%	81.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$1.100M
YoY Change	-100.0%	-100.0%	-26.67%
Total Short-Term Liabilities	$48.03M	$48.03M	$29.89M
YoY Change	48.05%	60.68%	53.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$24.70M	$26.80M	$13.60M
YoY Change	24.12%	97.06%	-25.27%
Total Long-Term Liabilities	$24.70M	$26.80M	$13.60M
YoY Change	24.12%	97.06%	-29.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.03M	$48.03M	$29.89M
Total Long-Term Liabilities	$24.70M	$26.80M	$13.60M
Total Liabilities	$72.71M	$74.86M	$43.50M
YoY Change	38.82%	72.09%	11.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$445.6M	-$411.6M	-$371.0M
YoY Change	6.59%	10.94%
Common Stock	$728.3M	$723.6M	$602.5M
YoY Change	19.87%	20.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$282.6M	$312.0M	$231.3M
YoY Change
Total Liabilities & Shareholders Equity	$355.4M	$386.9M	$274.8M
YoY Change	46.94%	40.77%	-25.5%

Cashflow Statement

Concept	2018 Q3	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	-$34.03M	-$43.24M	-$40.65M
YoY Change	-27.66%	6.37%	-200.47%
Depreciation, Depletion And Amortization	$2.730M	$1.200M	$2.000M
YoY Change	42.93%	-40.0%	11.73%
Cash From Operating Activities	-$36.98M	-$57.73M	-$30.76M
YoY Change	17.96%	87.68%	-7.43%
INVESTING ACTIVITIES
Capital Expenditures	-$4.220M	-$5.500M	-$7.310M
YoY Change	-57.16%	-24.76%	32.67%
Acquisitions
YoY Change
Other Investing Activities	$4.210M	-$2.310M	$80.44M
YoY Change	-70.58%	-102.87%	-257.48%
Cash From Investing Activities	-$10.00K	-$7.810M	$73.13M
YoY Change	-100.22%	-110.68%	-229.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	140.0K	103.8M	33.73M
YoY Change	-87.83%	207.59%	25846.15%
NET CHANGE
Cash From Operating Activities	-36.98M	-57.73M	-30.76M
Cash From Investing Activities	-10.00K	-7.810M	73.13M
Cash From Financing Activities	140.0K	103.8M	33.73M
Net Change In Cash	-36.85M	38.21M	76.10M
YoY Change	43.22%	-49.79%	-184.85%
FREE CASH FLOW
Cash From Operating Activities	-$36.98M	-$57.73M	-$30.76M
Capital Expenditures	-$4.220M	-$5.500M	-$7.310M
Free Cash Flow	-$32.76M	-$52.23M	-$23.45M
YoY Change	52.37%	122.73%	-15.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001125345
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42237385	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MACROGENICS INC
	mgnx	Contract With Customer Liability Increasefrom Cash Receipts ContractWithCustomerLiabilityIncreasefromCashReceipts	500000	USD
	mgnx	Fair Value Of Warrants Received FairValueOfWarrantsReceived	0	USD
	mgnx	Fair Value Of Warrants Received FairValueOfWarrantsReceived	6130000	USD
	mgnx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-655000	USD
	mgnx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-516000	USD
	mgnx	Proceedsfrom Stock Options Exercised And Espp Purchases ProceedsfromStockOptionsExercisedAndESPPPurchases	667000	USD
	mgnx	Proceedsfrom Stock Options Exercised And Espp Purchases ProceedsfromStockOptionsExercisedAndESPPPurchases	1125000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2451000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1767000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13643000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17836000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38581000	USD
CY2018Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37181000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-61000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	17000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	611270000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	723196000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4621008	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4621008	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5367754	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5367754	shares
CY2017Q4	us-gaap	Assets Assets	373883000	USD
CY2018Q2	us-gaap	Assets Assets	386891000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	322298000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	322054000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	USD
CY2018Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	19000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	63000	USD
CY2018Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	93455000	USD
CY2018Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	62216000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	93394000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	62233000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84098000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116627000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211727000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	238661000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	32529000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	26934000	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36859077	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42229011	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	369000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	422000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	27318000	USD
CY2018Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	23947000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3871000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	42845000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	83108000	USD
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	63148000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	118053000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	1048000	USD
CY2018Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	905000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	11253000	USD
CY2018Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	10880000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7202000	USD
CY2018Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7999000	USD
CY2018Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7742000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	13637000	USD
CY2018Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	15948000	USD
CY2018Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	19576000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3981000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2540000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.14
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.21
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.35
CY2018Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	31700000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8384000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15846000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11134000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20369000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2026000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-684000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4194000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-773000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6185000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8215000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1866000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3371000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-65000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5511000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	525000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	22000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-771000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-298000	USD
CY2017Q4	us-gaap	Investments Investments	93394000	USD
CY2018Q2	us-gaap	Investments Investments	62233000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	74645000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	74855000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	373883000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	386891000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	49755000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	48027000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	33842000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	104384000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	64773000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	11576000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-66086000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-89026000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-40654000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-78310000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-43244000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-92780000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-41179000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-79388000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-44314000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-94524000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	383000	USD
CY2018Q2	us-gaap	Other Assets OtherAssets	151000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1602000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7346000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	25000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	40000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	79000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-40629000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-78311000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-43204000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-92701000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	175000	USD
CY2018Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	175000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6300000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	525000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1078000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1070000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1744000	USD
CY2017	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	56937000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	86491000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8795000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20023000	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3151000	USD
CY2018Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3173000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	33175000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	103259000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	130505000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	118090000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	700000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49983000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57491000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34461000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67262000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52014000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	97684000	USD
CY2017Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	298000	USD
CY2018Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-312340000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-411599000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-318819000	USD
CY2017Q2	us-gaap	Revenues Revenues	1666000	USD
	us-gaap	Revenues Revenues	3720000	USD
CY2018Q2	us-gaap	Revenues Revenues	18834000	USD
	us-gaap	Revenues Revenues	23529000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3602000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7063000	USD
CY2018Q2	us-gaap	Share Based Compensation ShareBasedCompensation	4163000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7595000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3108933	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3700000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	114632	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1163517	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.29
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	18118000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4504642	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	185773	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5367754	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.79
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.94
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	18081000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5141748	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	21.75
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.35
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	23.50
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	27.78
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	17733000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y1M6D
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	299238000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	312036000	USD
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2018Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35784804	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35373799	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42153813	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39559599	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35784804	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35373799	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	42153813	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39559599	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35784804	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35373799	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42153813	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39559599	shares

Files In Submission

Name	View Source	Status
0001125345-18-000084-index-headers.html	Edgar Link	pending
0001125345-18-000084-index.html	Edgar Link	pending
0001125345-18-000084.txt	Edgar Link	pending
0001125345-18-000084-xbrl.zip	Edgar Link	pending
exhibit31-1q22018.htm	Edgar Link	pending
exhibit31-2q22018.htm	Edgar Link	pending
exhibit32-1q22018.htm	Edgar Link	pending
exhibit32-2q22018.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mgnx-063018x10xq.htm	Edgar Link	pending
mgnx-20180630.xml	Edgar Link	completed
mgnx-20180630.xsd	Edgar Link	pending
mgnx-20180630_cal.xml	Edgar Link	unprocessable
mgnx-20180630_def.xml	Edgar Link	unprocessable
mgnx-20180630_lab.xml	Edgar Link	unprocessable
mgnx-20180630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MGNX
MACROGENICS INC Stock $mgnx

2018 Q3 Form 10-Q Financial Statement

#000112534518000084 Filed on August 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGNX MACROGENICS INC Stock $mgnx

2018 Q3 Form 10-Q Financial Statement

#000112534518000084 Filed on August 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGNX
MACROGENICS INC Stock $mgnx